x

Editorial

The Fight against Coronavirus Is Our Business

ATHENS — This is a very difficult decision: what does a leader who has already shut down his country's economy once do? On the one hand, because of the first lockdown, the number of infections – and deaths – from the Coronavirus have been significantly reduced, but at the same time, as a natural consequence, the economy suffered a huge contraction. But what do you do when the virus returns?

This, unfortunately, is not a theoretical question.

It is a question facing the leaders of many countries today, from Spain to Greece to Cyprus.

In America, however, due to the fast-approaching elections of November 3, there is no thought of shutting down the economy again.

The loss from the first shutdown, as reflected in the national economic statistics, is enormous.

However, to give you a tangible picture, I note that one third of New York's 240,000 small businesses will never reopen. Specifically, 80,000 small businesses are gone.

I also note that no sector of the economy was hit more than that of restaurants and hotels. More than 80% of the city's restaurants did not pay their full rent in June.

So how can the leaders of the countries facing a second wave of Coronavirus decide to close their economies again?

How, on the other hand, do they risk having a large number of cases and deaths?

And finally, how will the schools open in a month or less?

Difficult decisions.

The only salvation is the invention of a drug or even better, a vaccine that will fight the Coronavirus.

But while they are working on it, there is another problem.

There is a fear of hasty approval of a vaccine for reasons of national prestige and glory. Such is the competition between states.

In this context, it is worth paying attention to the statement of Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases from a couple days ago:

"I do hope," he said, “that the Chinese and the Russians are actually testing the vaccine before they are administering the vaccine to anyone."

But U.S. scientists are also worried that the vaccine will not be tested properly here either, due to pressure from the White House for ‘an October surprise’ – a positive development that will benefit the re-election of the President shortly before the November elections.

In the middle of all this are, of course, the people, who do not know what to believe and what not to believe.

But more and more we will have to deal with the situation ourselves. Let's take our chances into our own hands: wear your masks, keep your distance, wash your hands.

RELATED

I read the story in the Associated Press twice to make sure what it said was accurate: The shareholders of Tesla, the electric car maker, have approved the compensation package for CEO, Elon Musk, amounting to about 44.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

1 of 2 Abducted Louisiana Children is Found Dead in Mississippi after Their Mother is Killed

JACKSON, Miss. (AP) — A Louisiana woman was found dead in her home Thursday, and her two young daughters were abducted and found hours later in Mississippi — one dead and the other alive, police said.

Licensing your intellectual property rights (IP) to a third-party as an additional source of revenue through the commercial exploitation of your IP or for expansion purposes can be an effective strategy to grow your business and extend your reach.

Cyprus and the European Parliament weren’t ready for Fidias Panayiotou, who had no qualifications to run for a seat in the 720-member body, which made him more qualified than most of the people in there.

To the Editor: Greeks are well aware that U.

Joseph Kenworthy was a British member of parliament who disliked and distrusted prime minister David Lloyd George’s Near East foreign policy and support of the Greeks.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.